Btg Plc.

Sir Brian Fender joined BTG as a Non-executive Director in 1992 and was appointed Chairman in July 2003. He is Chairman of the Nomination Committee. He was Chief Executive of the Higher Education Funding Council for England from 1995-2001. Prior to that he was Vice-Chancellor of Keele University, Associate Director and Director of the Institut Laue-Langevin in Grenoble, France and Chairman of the Science Board of the UK's Science and Engineering Research Council. He is a graduate and Fellow of Imperial College. He is currently a member of the University Grants Committee, Hong Kong, President of the National Foundation for Educational Research, and a Director of Higher Aims Ltd, a private consultancy involved in higher education and research management. Sir Brian is a Fellow of the Institute of Physics and the Royal Society of Chemistry and a Companion of the Chartered Management Institute. He has honorary degrees or fellowships from 11 universities and colleges.

Alison Wood joined BTG on 7 September 2004. Alison is currently a Group Managing Director of BAE Systems and of NITEworks, a joint UK Ministry of Defence and industry partnership looking at improving future UK military capabilities. Alison was appointed as a Managing Director within BAE Systems in 1999 and was subsequently appointed as Group Director of Strategy/M&A. From 1991 to 1999, Alison held various positions with British Aerospace plc, culminating in her role as Director of Corporate Strategy and Planning. Prior to this, Alison was a strategy consultant with Outram Cullinan & Company and a research associate with Booz Allen & Hamilton Inc. Alison holds an MA in Engineering, Economics and Management from Oxford and an MBA from Harvard.

Christine Soden became Chief Financial Officer and Company Secretary of BTG on 1 July 2005. Before joining BTG she was Chief Financial Officer of Oxagen Limited, a privately owned drug discovery company, where she was responsible for the finance, IT, legal and operations functions. From 1996 until 1999, Christine was Finance Director of Chiroscience Group plc then Chief Financial Officer of Celltech Chiroscience plc following the merger of the two companies. Prior to this, Christine spent over four years as Group Financial Controller and Head of Tax and Treasury at Medeva plc. Christine has a BSc in mathematics from Durham and is a qualified Chartered Accountant.

William J. Jenkins,M.D. has been a non-executive director since July 2000. He serves on our Audit and Nominating and Corporate Governance Committees. Until March 1999, Dr. Jenkins was the Head of Clinical Development and Regulatory Affairs Worldwide and a member of the Executive Committee at Novartis Pharma AG in Switzerland. Dr. Jenkins is a consultant to the pharmaceutical industry and to private equity and venture capital firms and a non-executive director of BTG plc and Monogram Biosciences, Inc. and a member of the Scientific Advisory Boards of BBBiotech Ventures II, Evotec, AG (where he serves as chairman) and Nicholas Piramal India Ltd.. Dr. Jenkins holds a B.A., M.D., and other advanced degrees from Cambridge University in England, as well as advanced degrees from the Royal College of Physicians, United Kingdom and from London University.